Examples of these drugs include: Abaloparatide (Tymlos) and Teriparatide (Forteo) for osteoporosis Carfilzomib (Kyprolis) for multiple myeloma Degarelix (Firmagon) for advanced prostate cancer Dulaglutide (Trulicity), exenatide (Byetta), liraglutide (Victoza), lixisenatide (Adlyxin), and semaglutide (Ozempic, Wegovy) for type 2 diabetes Enfuvirtide (Fuzeon) for HIV Linaclotide (Linzess) for irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation Teduglutide (Gattex) for malabsorption (when you don't absorb nutrients from your stomach and intestines very well) Ziconotide (Prialt) for severe chronic pain Unlike some cosmetics and supplements, these drugs have been well-researched and are tightly regulated by the FDA
By week 12, all three receptor pathways are fully engaged and working together, which is why the transition from month 3 to month 6 often shows accelerated weight loss compared to the initial adaptation period
doi: 10.3233/JAD-2008-14103 65 Donoso-QuezadaJAyala-MarSGonzalez-ValdezJ
26 , 1690.e11690.e4 (2020)
Additionally, this medication is not recommended for pregnant or breastfeeding women, as its safety in these populations has not been established
Instead, we always recommend combining weight loss medication with lifestyle habits that help support a healthy weight